Læknaneminn - 01.04.1991, Síða 54

12. Jarvinen Y. ofl. glucose intolerance, plasma
lipoprotein & tissue lipoprotein lipase activities in
body builders. European journal of applied
physiology 53: 253-259, 1984.
13. Cuppers H. ofl. Glucose tolerance, serum insulin,
serum lipids in athletes : Diabetes and exercise: M.
Berger, P Cristacopoulus, .1 Wahren (Eds), Bern
Switzerland, Hans Huber publ. 1982. bls 115-165.
14. Berg. ofl. Lipoprótein cholesterol in well trained
athletes; preliminary communication; reduced HDL-
C in power athletes. International journal of sports
medicine. 1: 137-138, 1980.
15.. Clarkson P. M.ofl. HDL-Cinyoungadultweight
lifters, runners and untrained subjects. Human
biology. 53: 251-257, 1987.
16.. Farrel P. A. ofl. A comparison of plasma
cholesterol, triglyceride and HDL-C in speed skaters,
weight lifters and non athletes. European journal of
applied physiology 48: 77-82, 1982.
17. Fang C.L. ofl. Exercise modality and selected
coronary risk factors; a multivariate approach.
Medicine and science in sports end exercise 20: 455-
462, 1985.
18.. Stone M.H. ofl. :Resistive training and selected
effects. Medical clinincs of North America. 69: 109-
121, 1985.
19. Hurley B.F. : Effects of resistive training on
lipoprotein lipid profiles: a comparisom to aerobic
exercise training. Medicine and science in sports and
exercise 21: des 1989 bls.689.
20. Hurley B.F. ofl. : Glucose tolerance and lipid
lipoprotein levels in middle aged powerlifters.
Clincal physiology 7 : 11-19, 1987.
21.. Elliot D.L. ofl : Characteristics of anabolic-
androgenic steroid free competitive inale and fernale
bodybuilders. The physician and sportsmedicine 15:
169-179, 1987.
22. Morgan D.W.ofl :HDL-Cconcentration in weight
trained, endurance trained and sedentary females. The
physician and sportsmedicine 14: 166-181, 1987.
23. MillerW.C.: Dietcomposition.energy intakeand
nutritional status in relation to obesity. Medicine and
science in sports and exercise mars 1991. bls280.
24. Hunninghake D. workshop IV, national
cholesterol education program guidlines: are they
clinically relevant? American journal of medicine 21
feb. 1991.
25. Katan M.B. Dietary management of the
hyperlipidemic patient, Lipid review. vol. 1 No. 1
Nóv. 87.
26. Nikkila M. ofl. HDL-C and triglyceride an
markers of angiographically assessed coronary artery
disease. British heartjournal 63: 78-81, 1990.
27. Miller N ofl. The tromsö heart study, HDL and
coronary artery disease, Lancet 1977 i :965-8.
28. ZampognaAofl. Relationshipbetween lipidsand
occlusive coronary arteri disease. Archieves of
internal medicine. 1980 :140, 1067-9.
29. Kern F. Normal plasma cholesterol in an 88 year
old man who eats 25 eggs a day. The New England
journal of medicine. 28 mars91. bls 896.
30 Mettinen T.A ofl. Regulation of serum cholesterol
bycholesterol absorbtion, Agents Actionssuppl. 1988
: 26: 53-56.
31. Franz M.J. ofl. How enthuastically should the use
of monounsaturated fats be encouraged? The Diabetes
educator, vol 15, No 6 bls 494. 1990.
32. Colgan M.: PreventCancernow ! Colgan Institute
publication 1990.
33. Dreon D.M ofl The effect of polyunsaturated fat
vs monounsaturated fat on plasma lipoprotein.
JAMA, 9. maí 1990.
34. Linder M.C. (ed.) Nutritional biochemistry and
metabolism. Elsevier útg. 1985. bls 338.
35. Keys A. Lowering plasma cholesterol by diet,
New England Journal of medicine, 315:585, 1986.
36. Erasmus U. Fats and oils, Vancouver: Alive
Books, 1986.
37. Frohlich J. ofl. Clinical significans of serum HDL
cholesterol. Heartbeat, journal of the intern. society
and fed. of cardiology. No 3, sept. 1989.
38. Devlin, Thomas M. (ritstjóri). Textbook of
biochemistry, 2. útgáfa. New York, Wiley and sons,
1986. Bls. 402-411.
39. Witztum, Joseph L. Current approaches to drug
therapy for the hypercholesterolemic patient.
Circulation 1989; 80:1101 -1114.
40. Svanur Kristjánsson stud. med^: úr B.S. verkefni
(óbirtar niðurstöður).
41. Læknablaðið, 77. árg. 2. tbl. Meðferð við hárri
blóðfitu: Samráðsfundur á vegum
landlæknisembættisins, bls. 59-60.
52
LÆKNANEMINN 1 1991 44. árg.